BIOMAT Database Logo BIOMAT Database Logo

Antiarrhythmic effect of a sotalol-mexiletine combination on induced ventricular tachycardia in dogs. 1993

F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
Laboratoire de Pharmacologie, Faculté de Médecine Saint Antoine, Paris, France.

Mexiletine was recently shown to antagonize the effects of sotalol on repolarization of canine Purkinje fibers. The significance of this interaction for the antiarrhythmic properties of these drugs remains unknown. The antiarrhythmic effects of sotalol and mexiletine alone and in combination on induced ventricular tachycardias (VTs) were assessed in 20 conscious dogs with chronic infarction. Electrophysiological measurements and programmed stimulation were performed before and after the infusion of sotalol (4 mg/kg) or mexiletine (4 mg/kg), and after infusion of the combination. The electrophysiological parameters didn't change after mexiletine. Sotalol alone and the combination both similarly prolonged the QT interval and VERP. Induction of VT by programmed stimulation was not prevented by mexiletine, but the cycle length of monomorphic VT was increased in 7 of 10 dogs. The induction of VT was prevented by sotalol (11/16 dogs), but VTs were not slowed significantly. Sotalol plus mexiletine prevented VT as did sotalol alone (11/16 dogs). The combination also increased the cycle length of VT in all eight dogs with monomorphic VT. Thus, the antagonism shown in vitro appears to have no consequences in this model. On the contrary, the sotalol-mexiletine combination showed some additive antiarrhythmic effects on induced VT in dogs.

UI MeSH Term Description Entries
D008801 Mexiletine Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties. KO-1173,KO1173,KOE-1173,Mexiletene,Mexiletine Hydrochloride,Mexitil,Mexitil PL,Mexityl,Novo-Mexiletine,KO 1173,KOE 1173,KOE1173,Novo Mexiletine
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D012032 Refractory Period, Electrophysiological The period of time following the triggering of an ACTION POTENTIAL when the CELL MEMBRANE has changed to an unexcitable state and is gradually restored to the resting (excitable) state. During the absolute refractory period no other stimulus can trigger a response. This is followed by the relative refractory period during which the cell gradually becomes more excitable and the stronger impulse that is required to illicit a response gradually lessens to that required during the resting state. Period, Neurologic Refractory,Periods, Neurologic Refractory,Refractory Period, Neurologic,Tetanic Fade,Vvedenskii Inhibition,Wedensky Inhibition,Inhibition, Vvedenskii,Inhibition, Wedensky,Neurologic Refractory Period,Neurologic Refractory Periods,Neuromuscular Fade,Neuromuscular Transmission Fade,Refractory Period, Neurological,Refractory Periods, Neurologic,Electrophysiological Refractory Period,Electrophysiological Refractory Periods,Fade, Neuromuscular,Fade, Neuromuscular Transmission,Fade, Tetanic,Neurological Refractory Period,Neurological Refractory Periods,Refractory Periods, Electrophysiological,Refractory Periods, Neurological,Transmission Fade, Neuromuscular
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study.
August 2010, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology,
F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardia.
May 1991, Journal of the American College of Cardiology,
F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
Effect of sotalol on RR interval variability during induced ventricular tachycardia.
August 1996, The American journal of cardiology,
F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
January 1981, Journal of cardiovascular pharmacology,
F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
Antiarrhythmic Agent Induced Ventricular Tachycardia.
January 2017, American journal of therapeutics,
F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.
September 1992, Journal of the American College of Cardiology,
F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
The effect of carbocromene on strophanthin-induced ventricular tachycardia in dogs.
January 1975, Basic research in cardiology,
F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias.
January 1984, Journal of cardiovascular pharmacology,
F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
The cellular electrophysiologic effect of a new amiodarone like antiarrhythmic drug GYKI 16638 in undiseased human ventricular muscle: comparison with sotalol and mexiletine.
January 2002, Current medicinal chemistry,
F Chézalviel, and J Weissenburger, and C Guhennec, and M Jagueux, and J M Davy, and L Vernhet, and V Simandoux, and J M Poirier, and G Cheymol
Termination of refractory ventricular tachycardia by a combination of intravenous sotalol and overdrive ventricular pacing.
July 1987, Clinical cardiology,
Copied contents to your clipboard!